Increasing use of observation among men at low risk for prostate cancer mortality

Journal of Urology

Volumn 193, Issue 3, 2015, Pages 801-806

  Ritch, Chad R ^a   Graves, Amy J ^c   Keegan, Kirk A ^d   Ni, Shenghua ^c   Bassett, Jeffrey C ^c   Chang, Sam S ^b   Resnick, Matthew J ^c   Penson, David F ^c   Barocas, Daniel A ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Urologic Surgery ^*  (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

age groups; comorbidity; continental population groups; prostatic neoplasms; therapy

Indexed keywords

AGED; ANCESTRY GROUP; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; COHORT ANALYSIS; COMORBIDITY; HIGH RISK POPULATION; HUMAN; INTERMEDIATE RISK POPULATION; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SURGERY; RETROSPECTIVE STUDY; VERY ELDERLY; MORTALITY; PROSTATE TUMOR; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; WATCHFUL WAITING;

AGED; AGED, 80 AND OVER; COHORT STUDIES; HUMANS; MALE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; WATCHFUL WAITING;

EID: 84922619184     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.08.102     Document Type: Article

References (24)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11
2. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969
3. P.C. Albertsen, J.A. Hanley, and J. Fine 20-Year outcomes following conservative management of clinically localized prostate cancer JAMA 293 2005 2095
4. G.L. Lu-Yao, P.C. Albertsen, and D.F. Moore Outcomes of localized prostate cancer following conservative management JAMA 302 2009 1202
5. L. Klotz, L. Zhang, and A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126
6. D.A. Barocas, J.E. Cowan, and J.A. Smith Jr. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database J Urol 180 2008 1330
7. M.R. Cooperberg, D.P. Lubeck, and M.V. Meng The changing face of low-risk prostate cancer: trends in clinical presentation and primary management J Clin Oncol 22 2004 2141
8. T.J. Daskivich, K. Chamie, and L. Kwan Overtreatment of men with low-risk prostate cancer and significant comorbidity Cancer 117 2011 2058
9. J.L. Warren, C.N. Klabunde, and D. Schrag Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Med Care 40 2002 IV-3
10. C.N. Klabunde, A.L. Potosky, and J.M. Legler Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258
11. S.R. Harlan, M.R. Cooperberg, and E. Elkin Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE J Urol 170 2003 1804
12. H. Wickham ggplot2: Elegant Graphics for Data Analysis 2009 Springer New York
13. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 2010 1117
14. A. Bill-Axelson, L. Holmberg, and H. Garmo Radical prostatectomy or watchful waiting in early prostate cancer N Engl J Med 370 2014 932
15. T.J. Wilt, M.K. Brawer, and K.M. Jones Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203
16. I. Thompson, J.B. Thrasher, and G. Aus Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106
17. J.L. Mohler, P.W. Kantoff, and A.J. Armstrong Prostate cancer, version 1.2014 J Natl Compr Canc Netw 11 2013 1471
18. C.P. Filson, F.R. Schroeck, and Z. Ye Variation in use of active surveillance among men undergoing expectant management for early-stage prostate cancer J Urol 192 2014 75
19. T.J. Daskivich, K.H. Fan, and T. Koyama Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer Ann Intern Med 158 2013 709
20. A.S. Hamilton, P.C. Albertsen, and T.K. Johnson Trends in the treatment of localized prostate cancer using supplemented cancer registry data BJU Int 107 2011 576
21. S.B. Zeliadt, A.L. Potosky, and R. Etzioni Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999 Urology 64 2004 1171
22. R.M. Hoffman, L.C. Harlan, and C.N. Klabunde Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study J Gen Intern Med 18 2003 845
23. V.L. Shavers, M.L. Brown, and A.L. Potosky Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer J Gen Intern Med 19 2004 146
24. A.S. Glass, J.E. Cowan, and M.J. Fuldeore Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era Urology 82 2013 60